We are pleased to confirm that Orphan Reach will be attending Outsourcing in Clinical Trials Nordics next week. Meet our Client Relationship Manager, who will be […]
We are delighted to be exhibiting at World Orphan Drug Congress, Barcelona in less than two weeks’ time. The conference agenda covers the strategic and commercial […]
Orphan Reach is extremely honoured to be part of this crucial Phase II COVID-19 trial at the forefront of clinical research. We are delighted to be […]
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 […]
There are some changes in the data protection law, so we wanted you to know that we've updated our Privacy Policy. Your trust is important to us, and we want to make sure you understand what these changes mean for you.
Please visit our Privacy Policy page for more information about our Privacy and Cookie Policy.